JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franzot, S. P.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franzot, S. P.
Right arrow Articles by Casadevall, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1999, p. 838-840, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Cryptococcus neoformans var. grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates

Sarah P. Franzot,1 Ira F. Salkin,2 and Arturo Casadevall3,*

Department of Pharmacology, Cornell University Medical College, New York,1 Wadsworth Center, New York State Department of Health, Albany,2 and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx,3 New York

Received 20 October 1998/Returned for modification 8 December 1998/Accepted 17 December 1998


    ABSTRACT
Top
Abstract
Text
References

Cryptococcus neoformans var. neoformans presently includes isolates which have been determined by the immunologic reactivity of their capsular polysaccharides to be serotype A and those which have been determined to be serotype D. However, recent analyses of the URA5 sequences and DNA fingerprinting patterns suggest significant genetic differences between the two serotypes. Therefore, we propose to recognize these genotypic distinctions, as well as previously reported phenotypic differences, by restricting C. neoformans var. neoformans to isolates which are serotype D and describing a new variety, C. neoformans var. grubii, for serotype A isolates.


    TEXT
Top
Abstract
Text
References

Mycology has traditionally relied upon phenotypic features, e.g., morphology, biochemistry, and the presence and nature of reproductive structures, to evaluate the relationship of fungi and to determine the appropriate identification of isolates (7, 22). However, such characteristics may show wide variation within species and may change as isolates are maintained in culture (17). Therefore, molecular techniques such as DNA fingerprinting, DNA sequence analysis, electrophoretic karotyping, and others have gained increasing importance in clarifying the taxonomy of several fungal genera and species (22, 23). In the present study we have used molecular tools to re-evaluate the taxonomic status of Cryptococcus neoformans var. neoformans.

C. neoformans (Sanfelice) Vuillemin is a heterothallic yeast frequently associated with systemic infections in immunocompromised patients, especially those with AIDS (6, 30). Isolates of the fungus have been divided into four distinct serotypes, A, B, C, and D, on the basis of the immunologic properties of their capsular polysaccharides (15, 35). Subsequent studies proposed that the serotypes be grouped into two separate varieties; serotypes A and D were designated as C. neoformans var. neoformans, while serotypes B and C were designated as Cryptococcus neoformans var. gattii Vanbrueseghem et Takashio (28, 33). A number of biochemical, epidemiological, and molecular characteristics have been used to distinguish these varieties, including their assimilation of L-malic acid (3) and D-proline (14), creatinine metabolism (26), and electrophoretic karyotypes (4, 34). While the taxonomic status of the two varieties has been generally accepted by mycologists, recent molecular typing of C. neoformans var. neoformans and C. neoformans var. gattii has suggested that they may be diverging into separate species (4).

While several investigators have focused on differences between the two varieties of C. neoformans, molecular analyses conducted by two of the present authors have demonstrated significant genotypic differences between the serotypes which comprise C. neoformans var. neoformans (16). The first evidence of such genetic division was obtained from fingerprint analyses with a C. neoformans repetitive element 1 (CNRE-1) probe, which hybridizes with moderately repetitive DNA sequences dispersed throughout the yeast's genome (32). The hybridization of CNRE-1 to SacI-digested DNA from A and D isolates resulted in such distinct restriction fragment length polymorphism (RFLP) patterns that they separated into two independent clusters in a dendrogram generated by distance analysis. The CNRE-1 probe hybridized effectively with DNA recovered from serotype A isolates and yielded 11 to 16 bands of various intensities. In contrast, the same probe hybridized poorly with DNA from D serotypes and yielded 5 to 11 bands, which were generally less intense than those obtained with serotype A isolates.

The second indication of molecular differences between the two serotypes was obtained through analyses of the nucleotide sequence of the URA5 gene. The URA5 gene of each of six isolates of serotypes A and D was amplified by PCR, and the nucleotide sequence of the cloned gene was determined for both strands (submitted to the GenBank database [16]). The nucleotide sequences of the URA5 gene of serotype A isolates differed from each other by an average of 3.0 ± 1.7 bases (15 pairwise comparisons). Alternatively, the number of nucleotide differences among D serotype isolates averaged 7.2 ± 3.4 (n = 15). The number of URA5 base differences obtained by pairwise comparisons between serotype A and D isolates was 41.9 ± 2.7 (n = 30). When bootstrap analyses were performed on phylogenetic trees based on these sequence data, the test isolates of serotype A and D clustered into two distinct and separate groups in 100% of the trees generated (16).

These findings are consistent with those reported by Guého et al. (18), who examined the phylogenetic relationships of C. neoformans by comparing the partial sequences of the most variable domain (D2) of the large subunit rRNA. These workers reported that B and C serotypes had identical sequences but the D2 sequences of A and D serotypes were significantly different. In fact, Guého and coworkers found that the sequence of this segment of the large subunit rRNA of D serotype isolates was closer to the corresponding sequences in B and C serotypes than to those of A serotype test strains.

While A and D serotypes are genetically dissimilar from each other, they are members of the same species. For example, Aulakh et al. (1) conducted reassociation studies of the DNAs from these two serotypes and reported 88 to 94% relatedness. Kwon-Chung (24) demonstrated that serotype A and D isolates are able to mate with each other and produce fertile progeny, i.e., the teleomorphic, basidiomycetous yeast Filobasidiella neoformans Kwon-Chung var. neoformans.

Despite the significant genetic differences, isolates of A and D serotype can be distinguished by only a few phenotypic characteristics (Table 1). For example, the two serotypes differ in their ability to assimilate thymine (21). When isolates of serotype D are grown on a medium containing creatinine, dextrose, bromothymol blue, and thymine, they convert the pyrimidine to beta -isobutyric acid. In contrast, serotype A isolates cannot utilize thymine, and colonies remain cream colored when grown on the same medium (21). Additionally, there are the antigenic properties of the polysaccharide capsule resulting from differences in the extent of xylose present in the glucuronoxylomannan capsular backbone (8). However, serotyping of isolates is an involved procedure not readily performed in the average clinical microbiology laboratory. Then, too, Cleare and Casadevall recently observed an annular pattern of immunofluorescence binding to the immunoglobulin M monoclonal antibody (MAb) 13F1 with serotype A isolates but a punctate pattern with serotype D isolates (10). While the differentiation of C. neoformans isolates on the basis of their serotypes is widely accepted, Cherniak et al. recently demonstrated that the glucuronoxylomannan structure and serotype of isolates recovered from clinical specimens can change during the course of infection (9). Therefore, the serotype of an isolate may not be as stable a phenotypic character as had previously been perceived.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Differences among the three varieties of C. neoformansa

Although relatively few serotype-specific serological reagents are available, several methods for serotype discrimination have been described (reviewed in reference 6). Ikeda et al. (20) developed commercially available serological reagents which discriminate the serotypes based on the presence of one or more of eight antigenic factors (Table 1). MAbs that react with specific serotypes have also been generated. Dromer et al. (11) developed MAb E1, which reacts primarily with serotype A isolates, while Ikeda et al. (19) isolated a MAb specific for serotype D strains. As mentioned above, the differential binding of MAb 13F1 to the capsular material of serotype A and D strains indicates that it can be used as another reagent for serotype discrimination (10).

There are also epidemiological and clinical differences between the two serotypes. While the overwhelming majority of isolates recovered from AIDS patients throughout the world are serotype A, infections due to serotype D in such individuals are more prevalent in isolated geographic areas, especially France, Italy, and Denmark (2, 12). Moreover, infections due to serotype D are more strongly correlated than those caused by serotype A to older patients, the skin, and the use of corticosteroids (13). Finally, despite the fact that the teleomorph F. neoformans is considered to be a heterothallic, basidiomycetous yeast composed of two mating types, a and alpha , serotype A isolates recovered from clinical cases and the environment have all proven to be alpha  mating types. Observation of both mating types and successful mating pairs has been restricted to serotype D isolates.

Therefore, we propose on the basis of this phenotypic and genotypic evidence to separate serotype A and D isolates into distinct varieties of the same species. Since the original description of C. neoformans var. neoformans was based on a D serotype (24), we suggest retaining this variety for isolates of this serotype. We propose a new variety, Cryptococcus neoformans var. grubii, to include only A serotypes. The descriptions of these two varieties are as follows.

Cryptococcus neoformans (Sanfelice) Vuillemin var. neoformans emend. Franzot, Salkin, et Casadevall. The same characteristics as those previously described for Cryptococcus neoformans var. neoformans, except that this emendation restricts the variety to D serotypes of the anamorphic species as determined by the reactivity of their capsular polysaccharide with rabbit sera. The variety may be further distinguished by the RFLP patterns of 5 to 11 bands of limited intensity obtained with the CNRE-1 probe of SacI-digested genomic DNA. Additionally, the variety is characterized by 7.2 ± 3.4 nucleotide differences in the URA5 gene as determined through PCR amplification and sequencing of the cloned gene. Teleomorph: Filobasidiella neoformans var. neoformans. Holotype: Isolated from peach juice and deposited in Centraalbureau voor Schimmelcultures as CBS 132.

Cryptococcus neoformans var. grubii Franzot, Salkin, et Casadevall, var. nov. Anamorphus ut in Cryptococcus neoformans var. neoformans simili sed ab hac varietate differt: capsulae "polysaccharide" serotypum A vocatum continentes; RFLP ordinatione 11-16 fasciarum ab exemplo CNRE-1 vocato, secundum concoctionem DNA enzymato SacI vocato; gens URA5 vocata 3.0 ± 1.7 "nucleotide" diversitate secundum PCR et DNA seriem praebens. Teleomorphys est Filobasidiella neoforans var. neoformans. Holotypus: In fluido ossis posterioris ex homo sapiens morbo Hodgkin's vocato lectus est, apud Durham, in Durham comitatu North Carolinsium finium, in imperio United States CSF cultura 898, 15 February 1978, e DUMC 135.97, cultura H99, NYSD 1649. In Museo Noveboracensis finibus herbario.

The same characteristics as those previously described for Cryptococcus neoformans var. neoformans, except that Cryptococcus neoformans var. grubii is restricted to "A" serotypes of the anamorphic species as determined by the reactivity of their capsular polysaccharide with rabbit sera. The variety may be further distinguished by the RFLP patterns of 11 to 16 bands of variable intensity obtained with the CNRE-1 probe of SacI-digested genomic DNA. Additionally, the variety is characterized by 3.0 ± 1.7 nucleotide differences in the URA5 gene as determined through PCR amplification and sequencing of the cloned gene. Teleomorph: Filobasidiella neoformans var. neoformans. Holotype: Isolate H99 recovered from Hodgkin's disease patient and deposited under accession no. NYSD 1649, New York State Herbarium, Albany, N.Y. Etymology: The specific epithet grubii was selected to honor David Gruby, 19th-century scholar, physician, and scientist, who was the first to recognize and prove that dermatophytic infections are caused by fungi.


    ACKNOWLEDGMENTS

We thank John Krug for the preparation of the Latin description and John Perfect and Wiley Schell for supplying strain H99.

A.C. is supported by a Burroughs Wellcome Fund Development Therapeutics Award and National Institutes of Health grants AI-22774, AI-13342, and HL59842.


    FOOTNOTES

* Corresponding author. Mailing address: Albert Einstein College of Medicine, 1300 Morris Park Ave., Golding Bldg., Room 701, Bronx, NY 10461. Phone: (718) 430-4259. Fax: (718) 430-8701. E-mail: casadeva{at}aecom.yu.edu.


    REFERENCES
Top
Abstract
Text
References

1. Aulakh, H. S., S. E. Straus, and K. J. Kwon-Chung. 1981. Genetic relatedness of Filobasidiella neoformans (Cryptococcus neoformans) and Filobasidiella bacillispora (Cryptococcus bacillispora) as determined by DNA base composition and sequence homology studies. Int. J. Syst. Bacteriol. 31:97-103.
2. Bennett, J. E., K. J. Kwon-Chung, and D. Howard. 1984. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am. J. Epidemiol. 105:582-586[Abstract/Free Full Text].
3. Bennett, J. E., K. J. Kwon-Chung, and T. S. Theodore. 1978. Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia 16:167-174[Medline].
4. Boekhout, T., A. van Belkum, A. C. Leenders, H. A. Verbrugh, P. Mukamurangwa, D. Swinne, and W. A. Scheffers. 1997. Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects. Int. J. Syst. Bacteriol. 47:432-442[Abstract/Free Full Text].
5. Brandt, M. E., S. L. Bragg, and R. W. Pinner. 1993. Multilocus enzyme typing of Cryptococcus neoformans. J. Clin. Microbiol. 31:2819-2823[Abstract/Free Full Text].
6. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, D.C.
7. Check, W. A. 1994. Molecular techniques shed light on fungal genetics. ASM News 60:593-596.
8. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512[Abstract/Free Full Text].
9. Cherniak, R., L. C. Morris, T. Belay, E. D. Spitzer, and A. Casadevall. 1995. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect. Immun. 63:1899-1905[Abstract].
10. Cleare, W., and A. Casadevall. 1998. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays. Clin. Diagn. Lab. Immunol. 5:125-129[Abstract/Free Full Text].
11. Dromer, F., E. Guého, O. Ronin, and B. Dupont. 1993. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J. Clin. Microbiol. 31:359-363[Abstract/Free Full Text].
12. Dromer, F., S. Mathoulin, B. Dupont, A. Laporte, and the French Cryptococcosis Study Group. 1996. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin. Infect. Dis. 23:82-90[Medline].
13. Dromer, F., S. Mathoulin, B. Dupont, L. Letenneur, O. Ronin, and the French Cryptococcosis Study Group. 1996. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. Clin. Infect. Dis. 23:91-96[Medline].
14. Dufait, R., R. Velhol, and C. De Vroey. 1987. Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation. Mykosen 30:483[Medline].
15. Evans, E. E. 1950. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64:423-430.
16. Franzot, S. P., B. C. Fries, W. Cleare, and A. Casadevall. 1998. Genetic relationship between Cryptococcus neoformans strains of serotypes A and D. J. Clin. Microbiol. 36:2200-2204[Abstract/Free Full Text].
17. Franzot, S. P., J. Mukherjee, R. Cherniak, L. C. Chen, J. S. Hamdan, and A. Casadevall. 1998. Microevolution of Cryptococcus neoformans in various laboratory environments resulting in differences in virulence and other phenotypes. Infect. Immun. 66:89-97[Abstract/Free Full Text].
18. Guého, E., L. Improvisi, R. Christen, and G. S. de Hoog. 1993. Phylogenetic relationships of Cryptococcus neoformans and some related basidiomycetous yeasts determined from partial large subunit rRNA sequences. Antonie van Leeuwenhoek 63:175-189[Medline].
19. Ikeda, R., S. Nishimura, A. Nishikawa, and T. Shinida. 1996. Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. Clin. Diagn. Lab. Immunol. 3:89-92[Abstract].
20. Ikeda, R., T. Shinoda, Y. Fukuzawa, and L. Kaufman. 1982. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J. Clin. Microbiol. 16:22-29[Abstract/Free Full Text].
21. Irokanulo, E. A. O., C. O. Akueshi, and A. A. Makinde. 1994. Differentiation of Cryptococcus neoformans serotypes A and D using creatinine dextrose bromothymol blue thymine medium. Br. J. Biomed. Sci. 51:100-103[Medline].
22. Kurtzman, C. P., and C. J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223[Abstract].
23. Kurtzman, C. P., and H. J. Phaff. 1987. Molecular taxonomy of yeasts, p. 63-94. In A. H. Rose, and J. S. Harrison (ed.), The yeasts, 2nd ed., vol. 1. Academic Press, New York, N.Y.
24. Kwon-Chung, K. J. 1975. A new genus Filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 67:1197-1200.
25. Kwon-Chung, K. J. 1976. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 68:942-946.
26. Kwon-Chung, K. J. 1991. The discovery of creatinine assimilation in Cryptococcus neoformans, and subsequent work on the characterization of the two varieties of C. neoformans. Zentralbl. Bakteriol. 275:390-393[Medline].
27. Kwon-Chung, K. J., I. Polacheck, and J. E. Bennett. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15:535-537[Abstract/Free Full Text].
28. Kwon-Chung, K. J., J. E. Bennett, and J. C. Rhodes. 1982. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie van Leeuwenhoek 48:25-38[Medline].
29. Madrenys, N., C. De Vroey, C. Raes-Wuytack, and J. M. Torres-Rodriguez. 1993. Identification of the perfect state of Cryptococcus neoformans from 195 clinical isolates including 84 from AIDS patients. Mycopathologia 123:65-68[Medline].
30. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS---100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548[Abstract].
31. Salkin, I. F., and N. J. Hurd. 1982. New medium for differentiation of Cryptococcus neoformans serotype pairs. J. Clin. Microbiol. 15:169-171[Abstract/Free Full Text].
32. Spitzer, E. D., and S. G. Spitzer. 1992. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J. Clin. Microbiol. 30:1094-1097[Abstract/Free Full Text].
33. Vanbreuseghem, R., and M. Takashio. 1970. An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. Part II. Cryptococcus neoformans var. gattii var. nov. Ann. Soc. Belge Med. Trop. 50:695-702[Medline].
34. Wickes, B. L., T. D. E. Moore, and K. J. Kwon-Chung. 1994. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 140:543-550[Abstract].
35. Wilson, D. E., J. E. Bennett, and J. W. Bailey. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823[Medline].

Journal of Clinical Microbiology, March 1999, p. 838-840, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franzot, S. P.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franzot, S. P.
Right arrow Articles by Casadevall, A.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS